Cargando…
Prognostic factors for IB2-IIIB cervical cancer patients treated by radiation therapy with high-dose-rate brachytherapy in a single-institution study
PURPOSE: To evaluate the efficacy of radiotherapy in locally advanced cervical cancer, and to determine the factors affecting prognosis. MATERIAL AND METHODS: Clinical data of 211 patients with cervical cancer, treated at our institution between June 2014 and February 2017 were reviewed retrospectiv...
Autores principales: | Xiu, Yu-Ting, Meng, Fan-Xu, Wang, Zhuo, Zhao, Kang-Kang, Wang, Yun-Long, Chen, Zhi-Shen, Sun, Bao-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528829/ https://www.ncbi.nlm.nih.gov/pubmed/36199952 http://dx.doi.org/10.5114/jcb.2022.118674 |
Ejemplares similares
-
Lymphangiogenesis in cervical cancer evaluated by expression of the VEGF-C gene in clinical stage IB-IIIB
por: Franc, Magdalena, et al.
Publicado: (2015) -
From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience
por: Espenel, Sophie, et al.
Publicado: (2018) -
Definitive extended field intensity-modulated radiotherapy and concurrent cisplatin chemosensitization in the treatment of IB2-IIIB cervical cancer
por: Zhang, Guangyu, et al.
Publicado: (2014) -
Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2–IIIB Cervical Cancer
por: Kunos, Charles A., et al.
Publicado: (2014) -
Correction to: From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience
por: Espenel, Sophie, et al.
Publicado: (2018)